Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of 50.14% is 180% above its 5-year average of -62.75%, near the low end of its 5-year range (-569.40%–4865.71%).
182.97% above its 12-month average of -60.43%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): -96.84%.
OPERATING MARGIN
50.14%
OPERATING MARGIN AVG TTM
-60.43%
OPERATING MARGIN AVG 3Y
-57.57%
OPERATING MARGIN AVG 5Y
-62.75%
OPERATING MARGIN AVG 10Y
-294.30%
OPERATING MARGIN AVG 15Y
-272.05%
OPERATING MARGIN AVG 20Y
-390.20%
CURRENT VS TTM AVG
+182.97%
CURRENT VS 3Y AVG
+187.09%
CURRENT VS 5Y AVG
+179.90%
CURRENT VS 10Y AVG
+117.04%
CURRENT VS 15Y AVG
+118.43%
CURRENT VS 20Y AVG
+112.85%
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Novavax, Inc.
Market Cap
$1.86B
Operating Margin
50.14%
TTM Avg
-60.43%
3Y Avg
-57.57%
5Y Avg
-62.75%
Market Cap
$1.87B
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$1.85B
Operating Margin
-3084.76%
TTM Avg
-3233.57%
3Y Avg
-1812.12%
5Y Avg
-1208.08%
Market Cap
$1.89B
Operating Margin
-1.12%
TTM Avg
-4.89%
3Y Avg
-11.52%
5Y Avg
-13.12%
Market Cap
$1.84B
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
-41.96%
5Y Avg
-55.47%
Market Cap
$1.89B
Operating Margin
-87.33%
TTM Avg
-133.51%
3Y Avg
-104.25%
5Y Avg
-284.42%
Market Cap
$1.83B
Operating Margin
2.61%
TTM Avg
3.43%
3Y Avg
5.52%
5Y Avg
6.07%
Market Cap
$1.89B
Operating Margin
-873.87%
TTM Avg
-1020.17%
3Y Avg
-1557.98%
5Y Avg
-1038.65%
Market Cap
$1.83B
Operating Margin
-29.92%
TTM Avg
-9.23%
3Y Avg
-24.36%
5Y Avg
-44.57%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Novavax, Inc. (NVAX) | $1.86B | 50.14% | -60.43% | -57.57% | -62.75% |
| Trevi Therapeutics, Inc. (TRVI)vs › | $1.87B | 0.00% | 0.00% | 0.00% | 0.00% |
| Immunome, Inc. (IMNM)vs › | $1.85B | -3084.76% | -3233.57% | -1812.12% | -1208.08% |
| BioLife Solutions, Inc. (BLFS)vs › | $1.89B | -1.12% | -4.89% | -11.52% | -13.12% |
| Palvella Therapeutics, Inc. (PVLA)vs › | $1.84B | 0.00% | 0.00% | -41.96% | -55.47% |
| Zymeworks Inc. (ZYME)vs › | $1.89B | -87.33% | -133.51% | -104.25% | -284.42% |
| Astrana Health, Inc. (ASTH)vs › | $1.83B | 2.61% | 3.43% | 5.52% | 6.07% |
| Agios Pharmaceuticals, Inc. (AGIO)vs › | $1.89B | -873.87% | -1020.17% | -1557.98% | -1038.65% |
| Sarepta Therapeutics, Inc. (SRPT)vs › | $1.83B | -29.92% | -9.23% | -24.36% | -44.57% |
| Azenta, Inc. (AZTA)vs › | $1.81B | -3.49% | -3.57% | -5.95% | -5.03% |
Gross Margin
93.7%
Operating Margin
50.1%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | -96.84% |
| 2026-03-31 | -11.06% |
| 2025-12-31 | 14.29% |
| 2025-09-30 | -252.70% |
| 2025-06-30 | 44.17% |
| 2025-03-31 | 77.33% |
| 2024-12-31 | -148.43% |
| 2024-09-30 | -158.58% |
| 2024-06-30 | 38.75% |
| 2024-03-31 | -147.81% |
| 2023-12-31 | -63.01% |
| 2023-09-30 | -569.40% |
| 2023-06-30 | 13.07% |
| 2023-03-31 | 4865.71% |
| 2022-12-31 | -84.73% |
| 2022-09-30 | -17.31% |
| 2022-06-30 | -259.76% |
| 2022-03-31 | 34.61% |
| 2021-12-31 | 113.55% |
| 2021-09-30 | -171.74% |
| 2021-06-30 | -116.04% |
| 2021-03-31 | -46.65% |
| 2020-12-31 | -65.38% |
| 2020-09-30 | -123.51% |
| 2020-06-30 | -47.91% |
| 2020-03-31 | -678.03% |
| 2019-12-31 | -325.60% |
| 2019-09-30 | -597.81% |
| 2019-06-30 | -1092.23% |
| 2019-03-31 | -1010.12% |
| 2018-12-31 | -759.13% |
| 2018-09-30 | -541.69% |
| 2018-06-30 | -389.80% |
| 2018-03-31 | -450.77% |
| 2017-12-31 | -458.94% |
| 2017-09-30 | -498.42% |
| 2017-06-30 | -616.03% |
| 2017-03-31 | -718.77% |
| 2016-12-31 | -1001.02% |
| 2016-09-30 | -1959.39% |
| 2016-06-30 | -3053.81% |
| 2016-03-31 | -1784.31% |
| 2015-12-31 | -1348.06% |
| 2015-09-30 | -508.80% |
| 2015-06-30 | -148.76% |
| 2015-03-31 | -246.16% |
| 2014-12-31 | -470.91% |
| 2014-09-30 | -240.92% |
| 2014-06-30 | -216.14% |
| 2014-03-31 | -192.78% |
| 2013-12-31 | -162.93% |
| 2013-09-30 | -318.18% |
| 2013-06-30 | -365.28% |
| 2013-03-31 | -261.02% |
| 2012-12-31 | -207.95% |
| 2012-09-30 | -118.80% |
| 2012-06-30 | -82.43% |
| 2012-03-31 | -160.86% |
| 2011-12-31 | -72.87% |
| 2011-09-30 | -79.23% |
| 2011-06-30 | -197.30% |
| 2011-03-31 | -890.89% |
| 2010-12-31 | -13788.24% |
| 2010-09-30 | -6022.29% |
| 2010-06-30 | -135257.14% |
| 2010-03-31 | -10412.73% |
| 2009-12-31 | -19127.03% |
| 2009-09-30 | -4110.45% |
| 2009-06-30 | -27000.00% |
| 2009-03-31 | -33985.71% |
| 2008-12-31 | -13157.14% |
| 2008-09-30 | -5013.40% |
| 2008-06-30 | -2398.83% |
| 2008-03-31 | -1576.42% |
| 2007-12-31 | 524.01% |
| 2007-09-30 | -703.95% |
| 2007-06-30 | -5522.15% |
| 2007-03-31 | -1346.11% |
| 2006-12-31 | -507.42% |
| 2006-09-30 | -477.28% |
| 2006-06-30 | -838.86% |
| 2006-03-31 | -386.42% |
| 2005-12-31 | 298.93% |
| 2005-09-30 | -119.82% |
| 2005-06-30 | -225.70% |
| 2005-03-31 | -874.95% |
| 2004-12-31 | -484.26% |
| 2004-09-30 | -355.28% |
| 2004-06-30 | -244.26% |
| 2004-03-31 | -152.05% |
| 2003-12-31 | -75.59% |
| 2003-09-30 | -69.34% |
| 2003-06-30 | -203.60% |
| 2003-03-31 | -452.35% |
| 2002-12-31 | -287.93% |
| 2002-09-30 | -256.95% |
